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Zinc (Zn) is one of the essential trace elements. 
It is a structural component of a great number 
of proteins, including enzymes and transcrip-
tion factors, and it is essential for their biologi-
cal activity (1, 2). Zn has a variety of effects 
in the immune system (3). Zn-deficient mice 
have defects in natural killer cell–mediated cy-
totoxic activity, antibody-mediated responses, 
host defense against pathogens, and tumors (4–6). 
In contrast, Zn itself is cytotoxic, and it induces 
apoptosis in T and B cells (7). Therefore, cells 
have evolved a complex system to maintain a 
balance of Zn uptake, intracellular storage, and 
efflux (8–11). Two solute-linked carrier (Slc) 
protein families have been identified in Zn 
transport: the Zn transporter (Znt)/Slc30 and 
ZRT/IRT-related protein (Zip)/Slc39 (8, 11–13).   
Znt transporters reduce cytoplasmic Zn avail-
ability by promoting Zn efflux from the cyto-
plasm into the extracellular space or intracellular 
compartments. The Zip transporters increase 
cytoplasmic Zn availability by promoting ex-
tracellular Zn uptake and Zn release from com-
partments into the cytoplasm.
Zn has also been implicated as an intracel-
lular signaling molecule (14–17). A nematode 
ZnT1 orthologue, CDF1, positively affects 
Ras–extracellular signal-regulated kinase (ERK) 
signal transduction (18). Slc39a7/Zip7 was found 
to affect epidermal growth factor/insulin-like 
growth  factor  signaling  and  tamoxifen  resis-
tance of breast cancer cells (19). We showed 
that  Slc39a6/Zip6/Liv1  controls  the  nuclear 
localization of the Zn finger transcription fac-
tor Snail (20). In addition, Toll-like receptor 
4–mediated DC maturation is, at least in part, 
dependent on a Toll-like receptor 4–induced 
decrease in intracellular free Zn effected by a 
change in the gene expression profile of Zip 
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Zinc (Zn) is an essential nutrient and its deficiency causes immunodeficiency. However, it 
remains unknown how Zn homeostasis is regulated in mast cells and if Zn transporters are 
involved in allergic reactions. We show that Znt5/Slc30a5 is required for contact hypersen-
sitivity and mast cell–mediated delayed-type allergic response but not for immediate 
passive cutaneous anaphylaxis. In mast cells from Znt5/ mice, Fc receptor I (FcRI)–
induced cytokine production was diminished, but degranulation was intact. Znt5 was in-
volved in FcRI-induced translocation of protein kinase C (PKC) to the plasma membrane 
and the nuclear translocation of nuclear factor B. In addition, the Zn finger–like motif of 
PKC was required for its plasma membrane translocation and binding to diacylglycerol. 
Thus, Znt5 is selectively required for the mast cell–mediated delayed-type allergic response, 
and it is a novel player in mast cell activation.
© 2009 Nishida et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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bradyarrhythmia during their reproductive period. We dem-
onstrate in this paper that a Znt, Znt5, is required for the 
mast cell–mediated delayed-type allergic response but not the 
immediate response. Znt5 is required for the FcRI-induced 
translocation of PKC- to the plasma membrane and, there-
fore, for NF-B–dependent cytokine production. These ob-
servations provide the first genetic evidence that a Znt, Znt5, 
is required for immunological responses and has a selective 
role in allergic reactions.
RESULTS
Znt5 is highly expressed in BM-derived mast cells (BMMCs) 
but not required for mast cell development
There are eight known members of the Znt family (45). To 
examine the role of the Znts in mast cells, we checked the 
expression level of each family member in BMMCs by exam-
ining the ReFDIC (Reference Database of Immune Cells) 
(46). The database showed that Znt5 was among the Znts 
that were highly expressed in BMMCs (Fig. S1). The mes-
senger RNA (mRNA) level of Znt5 was also enhanced by 
FcRI stimulation (Fig. 1 A and Fig. S2). Because Znt5/ 
mice are available (44), we focused on Znt5 to clarify its role 
in mast cell function. First, we determined that Znt5 protein 
was expressed in BMMCs from WT but not Znt5/ mice 
(Fig. 1 B). We also determined that in the BMMCs, Znt5 
was mainly located in the Golgi (Fig. 1 C), as reported pre-
viously for other cell types (47, 48). Next, we investigated 
whether Zn homeostasis was disordered in Znt5/ mast 
cells using a cell-permeable Zn-specific fluorescent probe, 
Newport green DCF diacetate, which predominantly local-
izes to the cytoplasm. The Znt5/ BMMCs showed an in-
creased level of free Zn in the cytoplasm (Znt5+/+ = 0.0723 ± 
0.00225 µM; Znt5/ = 0.106 ± 0.0132 µM; P < 0.05; 
Fig. 1 D), indicating that the intracellular distribution of free 
Zn was impaired in the Znt5/ BMMCs.
We next asked if Znt5 was required for mast cell devel-
opment. Culturing BM cells from WT and Znt5/ mice in 
the presence of IL-3 yielded highly purified mast cell popula-
tions. These BMMCs, whether derived from WT or Znt5/ 
mice, were indistinguishable in morphology when stained 
with Alcian blue (Fig. S3 A). The growth rate and total cell 
numbers in these cultures, as well as the frequency of BMMCs 
as revealed by flow cytometric analysis of the surface expres-
sion of c-kit and FcRI, were equivalent (Fig. S3 B). In ad-
dition to the normal in vitro development of the mast cells, 
the number of mast cells, their morphology, and their ana-
tomical distribution in the ear, skin, and stomach of WT and 
Znt5/ mice were comparable (Fig. S4, A and B). Collec-
tively, these findings demonstrated that Znt5 is not required 
for mast cell development.
Znt5 is selectively required for the CHS but not  
the PCA reaction
We examined the roles played by Znt5 in vivo in PCA and 
CHS using the Znt5/ mice. We first tested the importance 
of Znt5 in the PCA model by evaluating the extravasation of 
and Znt family members (21). Furthermore, in mast cells, 
Fc receptor I (FcRI) stimulation induces an increase in in-
tracellular free Zn, a phenomenon called the “Zn wave” 
(22). These results support the idea that Zn is involved in in-
tracellular signaling and lead to the prediction that Znts have 
roles not only in maintaining Zn homeostasis but also in in-
tracellular signaling events (17). Along these lines, we pre-
viously showed that Zn might be required for mast cell 
activation  in  allergic  responses;  the  Zn  chelator  TPEN 
(N,N,N,N-tetrakis  (2-pyridylmethyl)  ethylenediamine)  in-
hibits FcRI-mediated NF-B activation and degranulation 
in mast cells (23). All of these results suggest that Zn has piv-
otal roles in mast cell function. However, it remains com-
pletely unknown how Zn homeostasis is regulated in mast 
cells and if Znts are involved in mast cell function.
Mast cells are major players in allergy responses such as im-
mediate- and delayed-type hypersensitivity reactions (24–26). 
Passive cutaneous anaphylaxis (PCA) and contact hypersensi-
tivity (CHS) are mouse models for in vivo immediate-type and 
delayed-type reactions, respectively (27–29). FcRI stimula-
tion activates several downstream pathways that initiate the al-
lergic inflammatory process by eliciting mast cell degranulation 
accompanied by the rapid release of preformed chemical me-
diators such as histamine and serotonin. This process plays crit-
ical roles in the immediate-type allergic response. In contrast, 
the  mast  cell–mediated  delayed  responses  and  IgE-induced 
chronic allergic inflammatory processes are mainly dependent 
on cytokine production (30, 31). One important question in 
mast cell biology is how the early signaling events after FcRI 
stimulation are integrated and how specific mast cell responses, 
such as immediate degranulation versus a delayed-type allergic 
reaction, are selected. It would be helpful to understand these 
mechanisms because the identification of molecules that selec-
tively regulate specific mast cell effector functions could pro-
vide targets for therapies for mast cell–mediated diseases.
FcRI stimulation can induce the de novo synthesis of 
proinflammatory cytokines such as IL-6 and TNF- (32, 33). 
In particular, both calcium and diacylglycerol (DAG) activate 
conventional protein kinase C (PKC) isoforms that mediate a 
critical positive signal necessary for cytokine production in 
mast cells (34, 35). In addition, conventional PKCs have two 
regions in their regulatory domain, C1 and C2, in common. 
The C1 region regulates the activation or translocation of 
PKC and has two cysteine-rich loops (Zn finger-like motifs) 
that interact with DAG or phorbol esters (36–40). The C2 
region mediates calcium binding. Recently, in T, B, and 
mast cells, PKCs were shown to be important for NF-B ac-
tivation  and  the  upstream  function  of  an  adaptor  protein 
complex composed of Bcl-10 and MALT1 (41–43). Collec-
tively, these studies indicate that the PKC/Bcl-10/MALT1/
NF-B cascade plays important roles in cytokine production. 
Although this linear cascade is well established, it still seems 
oversimplified. Additional molecules are likely to be involved 
in the regulation of the PKC–NF-B signaling pathway.
Inoue et al. (44) reported that mice deficient in Znt5 
show severe osteopenia and male-specific sudden death from JEM VOL. 206, June 8, 2009 
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transcription of the genes for IL-6, IL-1, MCP, and TNF- 
(Fig. 2, C and D). The Znt5/ ears also showed a decrease in 
the transcription level of the genes for chemokines such as 
MIP-2 (CXCL2; Fig. 2 C). From these results, we concluded 
that Znt5 was selectively required for CHS, but not for PCA, 
in vivo. To determine whether defectiveness in CHS response 
in Znt5/ mice is caused by the lack of Znt5 in mast cell but 
not  in  other  environmental  cells  and  tissues,  we  checked 
KitW-sh/W-sh mice that had been engrafted with mast cell from 
either WT or Znt5/ mice. We found that engraftment with 
BMMCs from WT mice, but not Znt5/ mice, restored 
CHS response in KitW-sh/W-sh mice (Fig. 2 E). Consistent with 
these  results,  KitW-sh/W-sh  mice  reconstituted  with  Znt5/ 
BMMCs had significantly reduced FITC-induced cytokine 
expression level such as TNF- and IL-6 in the ear (Fig. 2 F). 
The number of mast cells per mm2 of dermis did not change 
between Znt5+/+ and Znt5/ BMMC-engrafted KitW-sh/W-sh 
mice (Fig. S5). Collectively, these findings showed that Znt5 
in mast cells is required for FITC-induced CHS responses.
Evans blue dye in the ears of mice that had been sensitized 
and challenged with an antigen. However, there was no no-
table difference in the extravasation kinetics or total amount 
of Evans blue dye in the ear in the WT and Znt5/ mice 
(Fig. 2 A), indicating that the mast cell–mediated PCA reac-
tion occurs normally in the absence of Znt5.
We next examined the CHS response, which is promoted 
by mast cell–derived proinflammatory cytokines. WT mice 
developed robust CHS responses to experimental hapten such 
as FITC, as assessed by tissue swelling at the site of hapten 
challenge, which reached a maximum 24 h after antigen stim-
ulation (Fig. 2 B). Consistent with a previous study (31), mast 
cell–deficient KitW-sh/W-sh mice developed a low-level FITC-
induced CHS reaction (Fig. 2 B). The Znt5/ mice exhib-
ited a similar defective CHS reaction (Fig. 2 B). Even 24 h 
after the antigen challenge, the increase in ear thickness of the 
Znt5/ mice was <45% of that of WT mice. Consistent with 
this result, the affected ear of the Znt5/ mice showed sig-
nificantly reduced FITC-induced cytokine production and 
Figure 1.  Localization of Znt5 in BMMCs. (A) RT-PCR of mRNAs encoding Znt family members (1–8), IL-6, and hypoxanthine-guanine phosphoribo-
syl transferase in BMMCs. BMMCs were untreated or treated with DNP–human serum albumin (HSA) for the indicated times. (B) Immunoblotting analysis 
of Znt5 in BMMCs. The BMMCs from Znt5+/+ and Znt5/ mice were analyzed by immunoblotting with an anti-Znt5 antibody. (C) Subcellular localization 
of ectopically expressed Flag-hZnt5 in BMMCs. Cells were retrovirally transfected with Flag-hZnt5 (described in Materials and methods), and then cells 
were double stained with FITC-conjugated anti-GM130 antibody (green) and Zenon-conjugated anti-flag antibody (red). Nuclei were labeled with DAPI 
(blue). Bar, 5 µm. (D) FACS analysis of intracellular free Zn using a Zn indicator, Newport green (left). Blue line, BMMCs from Znt5+/+ mice; orange line, 
BMMCs from Znt5/ mice. Histograms show mean fluorescent intensity (right). Data show mean + SD. **, P < 0.01 (two-tailed Student’s t test). A repre-
sentative dataset of the three (A, C, and D) or two (B) experiments performed, each of which gave similar results, is shown.1354 ROLE OF ZN TRANSPORTER IN ALLERGIC RESPONSE | Nishida et al.
Figure 2.  Normal PCA but defective CHS response in Znt5/ mice. (A) Analysis of PCA in Znt5+/+ mice (n = 12) and Znt5/ mice (n = 11) that 
received intradermal injections of IgE anti-DNP into the right ear and of saline into the left ear (control, non). After sensitization, mice were intravenously 
challenged with DNP-BSA. Data show mean + SD of the extravasation of Evans blue into the ears. (B) Analysis of the CHS response in Znt5+/+ (n = 14), 
Znt5/ (n = 14), and KitW-sh/W-sh (n = 11) mice. Znt5+/+, Znt5/, and KitW-sh/W-sh mice were sensitized with FITC. Ear swelling was measured at the indi-
cated times after hapten challenge. Data show mean + SEM. (C) Real-time quantitative RT-PCR of mRNAs for cytokines, chemokines, and GAPDH (loading 
control) expressed in the ears of Znt5+/ and Znt5/ mice challenged with FITC after 6 h. Data show the mean + SD (n = 3 per group). (D) Concentrations 
of IL-6 and TNF- in Znt5+/+ (IL-6, n = 10; TNF-, n = 5) and Znt5/ (IL-6, n = 10; TNF-, n = 5) mice challenged with FITC and measured by enzyme-JEM VOL. 206, June 8, 2009 
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phorylation and its subsequent degradation were impaired in 
the Znt5/ BMMCs (Fig. 4 D and Fig. S6). In contrast, the 
FcRI-induced activation of the mitogen-activated protein 
kinases (MAPKs) ERK1/2, JNK1/2, and p38 was not di-
minished in the Znt5/ BMMCs (Fig. 4 E). We also in-
vestigated  whether  Znt5  was  involved  in  FcRI-induced 
calcium-elicited signaling events. We monitored the tyrosine 
phosphorylation of LAT and PLC-1, which contributed 
calcium signaling (26, 50). As expected from the result shown 
in Fig. 3 A, LAT and PLC-1 tyrosine phosphorylation was 
apparently normal in Znt5/ BMMCs, as was the FcRI-
induced calcium influx (Fig. S7, A and B). Collectively, these 
results show that Znt5 was selectively required for FcRI-
mediated NF-B activation in BMMCs.
Znt5 is required for FcRI-mediated translocation of PKC- 
to the plasma membrane
Because IB phosphorylation decreased in Znt5/ BMMCs 
(Fig. 4 D and Fig. S6), we next sought to identify the upstream 
target of Znt5 that was involved in NF-B activation. Because 
FcRI-induced NF-B activation is dependent on PKC acti-
vation (23, 51), we examined the effect of Znt5 on the translo-
cation of PKC to the plasma membrane, a process important for 
PKC function. As shown in Fig. 5 (A and B), the FcRI- 
induced plasma membrane translocation of PKC- was dimin-
ished in the Znt5/ BMMCs, as was the PMA-induced plasma 
membrane translocation of PKC-, and a similar result was ob-
tained in the case of plasma membrane translocation of PKC- 
(not depicted). In addition, activity of PKC was reduced in the 
Znt5/ BMMCs compared with that in Znt5+/+ BMMCs 
(Fig. S8). Furthermore, we confirmed that transfected Znt5 
complementary DNA (cDNA) into the Znt5/ BMMCs res-
cued the defect in FcRI-induced plasma membrane transloca-
tion of PKC- (Fig. 5 C). To rule out the possibility that Znt5 
altered the PKC- expression level, we checked the protein 
level after FcRI stimulation and did not find any decrease 
compared with the level in WT BMMCs (Fig. S9). Together, 
these results showed that Znt5 is required for the FcRI-medi-
ated translocation of PKC- to the plasma membrane and that 
this effect on PKC- translocation is, at least in part, the mech-
anism underlying involvement of Znt5 in FcRI-induced   
NF-B activation, which results in cytokine production.
Zn finger–like motif of PKC- is important for the PMA-
induced plasma membrane translocation of PKC-
To understand the mechanisms by which Znt5 is involved in 
the plasma membrane translocation of PKC, we focused on 
Znt5 is required for FcRI-mediated cytokine production 
but not for degranulation in BMMCs
FcRI-induced  degranulation  and  the  production  of  lipid 
mediators play crucial roles in the PCA reaction, whereas cy-
tokine production is essential for the CHS response (49). To 
learn the basis for the selective defect in the CHS reaction 
of Znt5/ mice, we examined the capacities of Znt5/ 
BMMCs to degranulate, synthesize, and secrete lipid media-
tors and to produce cytokines. BMMCs derived from Znt5/ 
mice released similar amounts of -hexosaminidase to WT 
BMMCs in response to FcRI stimulation (Fig. 3 A), indicat-
ing that their ability to degranulate was intact. Furthermore, 
FcRI stimulation-induced lipid mediator secretion, such as 
that of leukotrienes C4, occurred normally in the Znt5/ 
BMMCs (Fig. 3 B). These results were consistent with the 
normal PCA reaction observed in the Znt5/ mice. How-
ever, the production of the FcRI-induced cytokines IL-6 
and TNF- was significantly reduced in Znt5/ BMMCs as 
compared with WT BMMCs (Fig. 3 C). Furthermore, PMA-
induced cytokine production was also diminished in Znt5/ 
BMMCs (Fig. 3 D). To rule out the possibility that the defect 
in cytokine production was caused by an impaired cytokine 
transport step in Znt5/ BMMCs, we checked the ability of 
LPS to induce cytokine production. As shown in Fig. 3 E, the 
LPS-induced production of the cytokines IL-6 and TNF- 
did not decrease in the Znt5/ BMMCs. These results indi-
cated that Znt5 is selectively required for FcRI-induced cy-
tokine production but not for degranulation in BMMCs.
Znt5 is involved in FcRI-mediated NF-B signaling
To define the molecular mechanisms responsible for the de-
fective cytokine production in Znt5/ BMMCs, we ana-
lyzed the cytokine mRNA levels using quantitative PCR. 
The FcRI stimulation of BMMCs led to a time-dependent 
increase in the IL-6 and TNF- mRNA level. However, the 
level of IL-6 and TNF- mRNA that was induced was sig-
nificantly lower in the Znt5/ BMMCs (Fig. 4 A). As ex-
pected  from  the  result  shown  in  Fig.  3  E,  the  levels  of 
LPS-induced  IL-6  and  TNF-  mRNA  in  the  Znt5/ 
BMMCs were not decreased as compared with those in WT 
(Fig. 4 B). Thus, Znt5 contributed to the FcRI-induced in-
crease of mRNA for IL-6 and TNF-.
We further analyzed whether Znt5 was involved in the 
FcRI-induced nuclear translocation of NF-B. As shown in 
Fig. 4 C, the FcRI-induced translocation of p65 to the nu-
cleus was significantly decreased in the Znt5/ BMMCs. 
Consistent with these results, FcRI-mediated IB phos-
linked immunosorbent assay. Data show mean + SD. (E) Tissue swelling response to vehicle or FITC in FITC-sensitized C57BL/6 WT mice (n = 19), KitW-sh/W-sh 
mice (n = 20), and KitW-sh/W-sh mice that had been selectively repaired of their mast cell deficiency by the intradermal injection of Znt5+/+ (n = 19) or 
Znt5/ (n = 17) BMMCs. Data show mean + SEM. (F) Cytokine response to vehicle or FITC in KitW-sh/W-sh mice that had been selectively repaired of their 
mast cell deficiency by the intradermal injection of Znt5+/+ or Znt5/ BMMCs. TNF- and IL-6 expression level were measured by real-time quantitative 
RT-PCR. The expression level of nonstimulation was set as 1. Data show the mean + SD (n = 4 per group). *, P < 0.05; **, P < 0.01. (two-tailed Student’s t 
test). Data are from at least two independent experiments with similar results, with two to six (A and B), three (C), two to five (D), seven to ten (E), or four 
(F) mice per group per experiment.
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Figure 3.  Defective cytokine production in Znt5/ BMMCs. (A) Degranulation of Znt5+/+ and Znt5/ BMMCs assessed as the release of –hex-
osaminidase. BMMCs from Znt5+/+ and Znt5/ mice were sensitized with anti-DNP IgE and stimulated with the indicated concentrations of DNP–HSA. 
As a control, BMMCs were stimulated with 1 µM ionomycin (Io). Data are the mean + SD. (B) Leukotriene synthesis in Znt5+/+ and Znt5/ BMMCs.  
Anti-DNP IgE-sensitized BMMCs from the two genotypes were stimulated with DNP–HSA at the indicated concentrations. Leukotrienes C4 was measured by 
enzyme-linked immunosorbent assay. Data show the mean + SD. (C) Enzyme-linked immunosorbent assay of IL-6 and TNF- in BMMCs from Znt5+/+ and 
Znt5/ mice sensitized with anti-DNP IgE and stimulated with the indicated concentrations of DNP–HSA. Data show the mean + SD. (D) PMA-induced 
cytokine production in Znt5+/+ and Znt5/ BMMCs stimulated with 50 and 500 ng/ml PMA. Data show the mean + SD. (E) LPS-induced cytokine produc-
tion in Znt5+/+ and Znt5/ BMMCs stimulated with 1 µg/ml LPS for the indicated time. <DL, below detection limit. Data show the mean + SD. A repre-
sentative dataset of the five (A), four (B), or three (C–E) experiments performed, each of which gave similar results, is shown. *, P < 0.05; **, P < 0.01 
(two-tailed Student’s t test).JEM VOL. 206, June 8, 2009 
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the C1 domain of PKC, the DAG-binding site. The C1 
domain of PKC has two Zn finger–like motifs (Fig. 6 A) 
(39, 40). Based on the known function of the Zn finger, we 
hypothesized that the Zn finger–like motifs of PKC are re-
quired for translocation of PKC- to the plasma membrane. 
To demonstrate this hypothesis, we designed WT–PKC-–
GFP and three mutant PKC-–GFP constructs (Fig. 6 A) 
and examined their ability to undergo PMA-induced plasma 
membrane translocation in HeLa cells.
The WT and C1BS mutant form of PKC-–GFP trans-
located equally well to the plasma membrane upon stimula-
tion by PMA (Fig. 6 B and Videos 1 and 3). In contrast, the 
C1AS and C1ABS double mutant constructs did not translo-
cate well and were retained in the cytoplasm (Fig. 6 B and 
Videos 2 and 4). These data suggested that the C1A Zn fin-
ger–like motif of PKC is important for its translocation to the 
plasma membrane and that this motif is a possible target for 
Znt5 and the likely binding site for DAG.
To test this hypothesis, we designed a biotin-conjugated 
PMA, an analogue of DAG (Biotinyl-PMA) (Fig. S10 A). 
Biotinyl-PMA induced cytokine production, just as PMA 
did (Fig. S10 B). Using Biotinyl-PMA, we assessed the bind-
ing ability of PMA to PKC-. Transfected PKC- WT and 
the C1AS mutant were extracted, run on a gel, and electro-
transferred to a polyvinylidine fluoride (PVDF) membrane 
under native conditions. As shown in Fig. 6 C, Biotinyl-PMA 
expected to bind the PKC WT construct, but its signal inten-
sity to the PKC C1AS mutant form was lower. Consistent 
with this result, the signal intensity of Biotinyl-PMA to PKC 
obtained from Znt5/ BMMCs was less than that to PKC 
from WT BMMCs (Fig. 6 D).
Figure 4.  Defective FcRI-mediated NF-B signaling in Znt5/ 
BMMCs. Cells were sensitized with anti-DNP IgE and subsequently stimulated 
for 1 or 3 h with the indicated concentrations of DNP–HSA (A) or LPS (B).  
The mRNAs for IL-6 and TNF- were measured by real-time quantitative 
RT-PCR. (A) FcRI-induced IL-6 and TNF- gene expression in Znt5+/+  
and Znt5/ BMMCs. The expression level of nonstimulation was set as 1. 
Data show the mean + SD. (B) LPS-induced IL-6 and TNF- gene expres-
sion in Znt5+/+ and Znt5/ BMMCs. Data show the mean + SD.  
(C, left) Confocal microscopy images of NF-B nuclear translocation in 
cells stimulated with FcRI (+) or not (). Anti-p65 antibody staining (p65, 
green) and DAPI (nuclei, blue). Bar, 5 µm. (C, right) Frequency of cells with 
nuclear NF-B. A Total of 50 cells were counted randomly in each experi-
ment, and the frequency of NF-B nuclear-translocated cells was calcu-
lated. Data show mean + SD. (D) IB phosphorylation and degradation 
were determined in Znt5+/+ and Znt5/ BMMCs stimulated with DNP-HSA 
for the indicated times. Cells were stimulated with FcRI and immunoblot-
ted with anti–phospho-IB, anti-IB, and tubulin. (E) FcRI-induced 
MAPK activation in Znt5+/+ and Znt5/ BMMCs. The cell lysates were 
blotted with anti–phospho-ERK1/2, anti–phospho-JNK1/2, and anti–phos-
pho-p38. The protein loading controls, which were used to normalize den-
sitometric values, were anti-ERK1/2, anti-JNK1, and anti-p38, respectively. 
A representative dataset of the three (A, B, C, D [IB], and E) or four  
(D [phospho-IB]) experiments performed, each of which gave similar 
results, is shown. *, P < 0.05; **, P < 0.01 (two-tailed Student’s t test).
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Figure 5.  FcRI or PMA-mediated plasma membrane translocation of PKC- was impaired in Znt5/ BMMCs. (A) FcRI (left)- or PMA (right)-
induced plasma membrane translocation of PKC in Znt5+/+ and Znt5/ BMMCs stimulated with DNP–HSA for the indicated times. The plasma membrane 
fraction was immunoblotted. The protein loading control, used to normalize densitometric values, was anti-actin. (B) PKC- plasma membrane transloca-
tion observed by confocal microscopy. Cells were stimulated with DNP–HSA for 15 min or not (Non). Polyclonal anti–PKC- antibody staining (green) and 
DAPI (blue) are shown. Bar, 5 µm. (C) Cells were double stained with anti–PKC- antibody (green) and Zenon-conjugated anti-flag antibody (red). Nuclei 
were labeled with DAPI. Bar, 5 µm. The percentage of cells in the plasma membrane translocation of PKC- is indicated on the right. 30 independent flag-
Znt5–positive cells in Znt5/ BMMCs were counted for each experiment. The values are the mean + SD. *, P < 0.05; **, P < 0.01, (two-tailed Student’s  
t test). A representative dataset of the three (A and B) or five (C) experiments performed, each of which gave similar results, is shown.
DISCUSSION
Znt5 selectively regulates the mast cell-mediated delayed-
type allergic response but not the immediate-type one
In this paper, we demonstrate that a Znt, Znt5, plays a crucial 
role in mast cell activation and mast cell–mediated allergic re-
actions. The mast cell is widely recognized as the most impor-
tant effector cell in IgE-associated allergic disorders such as 
anaphylaxis. Previous experiments with genetically mast cell–
deficient KitW/KitW-V or KitW-sh/KitW-sh mice have shown that 
mast cells are required for the IgE-mediated immediate-type JEM VOL. 206, June 8, 2009 
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Figure 6.  Zn finger–like motif of PKC is required for PMA-mediated translocation of PKC- to the plasma membrane. (A, top) Alignment of 
C1 domains of conventional PKC family members. Brown, cysteine residues; blue, histidine residues. I and II indicate residues involved in the two Zn ion 
coordination sites. Asterisk indicates the position of the cysteine residue replaced by serine in this experiment. (A, bottom) Constructs for the PKC-–GFP 
fusion protein and its mutants. WT PKC-–EGFP carried the gene for EGFP at its C terminus. In the C1 region of PKC-, there are two Zn finger–like se-
quences (top). To produce a Zn finger–like motif mutant form of PKC-, one cysteine residue in each of the two cysteine-rich regions was replaced by 
serine by site-directed mutagenesis. (B) PMA-induced plasma membrane translocation of PKC- observed by confocal microscopy. Localization of con-
structs in transfected HeLa cells stimulated with PMA or not (Non). F-actin and nuclei were labeled with phalloidin-rhodamine (red) and DAPI (blue), re-
spectively. Bar, 10 µm. (C) PMA binding to PKC- determined using biotinyl-PMA. 293T cells expressing WT–PKC-–GFP and C1AS–PKC-–GFP 
immunoblotted under native conditions (details in Materials and methods). The probes for PKC- and biotinyl-PMA were anti-GFP antibody and strepta-
vidin, respectively. (D) Cell lysates from Znt5+/+ and Znt5/ BMMCs resolved by native PAGE and blotted. (C and D) Densitometric values are shown below 
the blots. Data show mean + SD. *, P < 0.05; **, P < 0.01 (two-tailed Student’s t test). A representative dataset of three (B–D) experiments performed, each 
of which gave similar results, is shown.
allergic response (24, 27). Thus, the participation of mast cells 
in the immediate allergic reaction is well established. In addi-
tion to this classical role, much evidence has accumulated 
showing that mast cells play crucial roles in delayed-type aller-
gic reactions and chronic inflammatory diseases, including 
arthritis, experimental allergic encephalomyelitis, colitis, and 
CHS (28, 52–54). A variety of mast cell–derived cytokines 
and chemokines are likely to be essential for delayed-type 1360 ROLE OF ZN TRANSPORTER IN ALLERGIC RESPONSE | Nishida et al.
responsible for the activation of NF-B; for example, a PKC 
inhibitor suppresses NF-B activation (23, 51). Furthermore, 
PKC-–deficient mast cells are defective in IL-6 production 
(58). In this paper, we showed that Znt5 was required for the 
FcRI- or PMA-induced translocation of PKC- to the 
plasma membrane of BMMCs, and this requirement explains 
why Znt5 is needed for NF-B activation.
A related question is how Znt5 regulates the plasma mem-
brane translocation of PKC-, and several of our findings re-
late to this issue: the C1A Zn finger–like motif of PKC- 
was required for translocation of PKC to the plasma mem-
brane; mutating the C1A Zn finger–like motif of PKC- 
diminished its ability to bind PMA; PKC obtained from 
Znt5/ BMMCs showed decreased binding to PMA; Znt5 
was located in the Golgi; and Znt5/ BMMCs showed an 
increase in cytoplasmic free Zn. Because Znt5 was located in 
the Golgi, it probably promotes a Zn efflux from the cyto-
plasm into the Golgi. Because Znt5/ BMMCs had increased 
cytoplasmic free Zn, it seems likely that the available Zn in 
the Golgi was decreased concomitantly.
Together, these observations suggested the hypothesis 
that in the Znt5/ BMMCs, the Zn available to the C1A 
Zn finger–like motif of PKC as it transits through the Golgi 
is decreased, which results in an increase in Zn-free PKC. 
The mutation of the Zn-binding site of C1A interfered with 
the plasma membrane translocation of PKC, and this muta-
tion also diminished PMA binding to PKC. Collectively, our 
findings suggest that binding of Zn to the C1A of PKC in-
duces a conformational change required for DAG binding, 
which is itself required for the translocation of PKC to the 
plasma membrane. This hypothesis is supported by our data 
as well as by findings from other groups that Zn is involved 
in the translocation of PKC to the plasma membrane (59–61). 
Furthermore, in experiments using Znt5/ DT40 cells, 
Suzuki et al. (48, 62) showed that Znt5 expressed on the   
ER-Golgi membrane is required for the enzymatic activity of 
the Zn-dependent alkaline phosphatases (ALPs), which are 
processed from apoALPs to holoALPs in the ER-Golgi.
In summary, the results in this paper show that a Znt, 
Znt5, is selectively required for the mast cell–mediated de-
layed-type allergic response but not for the immediate-type 
allergic reaction. We further showed that Znt5 is required in 
the PKC-mediated NF-B signaling pathway. The identifi-
cation of Znt5 as a novel component of FcRI-mediated 
PKC activation sheds light on the molecular mechanisms of 
the processing and activation of PKC and of the Zn-mediated 
regulation of mast cell–dependent allergic responses, specifi-
cally of the delayed type.
Materials and Methods
Mice. C57BL/6J mice were obtained from CREA Japan. Znt5/ mice 
were provided by Y. Nakamura and T. Tanaka (University of Tokyo, To-
kyo, Japan, and RIKEN, Center for Genomic Medicine, Kanagawa, Japan). 
The generation of Znt5/ mouse was reported in detail by Inoue et al. (44). 
Mast cell–deficient KitW-sh/W-sh mice were provided by the RIKEN BioRe-
source Center. We obtained approval from the Animal Research Committee 
at RIKEN for all animal experiments performed.
allergic reactions and chronic inflammatory diseases. In fact, 
the mast cell–defective KitW/KitW-V mouse does not develop 
experimental allergic encephalomyelitis, and this defect is res-
cued by transferred WT BMMCs but not by IL-4–deficient 
BMMCs (55). These studies indicate that mast cell–derived 
cytokines are important in inflammatory diseases.
In this paper, we showed that Znt5/ mast cells had an 
intact degranulation process but impaired cytokine and che-
mokine production. Most importantly, Znt5/ mice had a 
defective mast cell–dependent delayed-type allergic reaction, 
i.e., CHS, but their immediate-type reaction, i.e., PCA, was 
unimpaired. Therefore, the Znt5/ mouse will be valuable 
for further dissection of the in vivo roles of mast cells in im-
mune and allergic responses and for analyzing the pathologi-
cal status of a variety of immune-related diseases.
Znt5 is required for FcRI-mediated NF-B activation  
and the translocation of PKC to the plasma membrane
Our results showed that Znt5 is important for FcRI-medi-
ated cytokine or chemokine production. As Znt5 was mainly 
located in the Golgi, we first examined whether Znt5/ 
mast cells were defective in cytokine processing/secretion. 
However, LPS-induced cytokine production was normal, 
indicating that the transport step was unaffected by the Znt5 
deficiency in mast cells. We also observed that FcRI in-
duced normal activation of LAT and PLC- and calcium 
mobilization. This observation is consistent with our result 
showing normal degranulation in Znt5/ BMMCs. From 
this, we deduced that the degranulation process can be in-
duced in Znt5/ mast cells as a result of intact calcium 
influx. Our results do not dispute the reported involvement 
of PKC in the degranulation process (35, 56), but this re-
quirement for PKC may be compensated by other signaling 
pathways in Znt5/ mast cells. Alternatively, the threshold 
of the degree of PKC activation required for degranula-
tion and that for NF-B activation might be different. To 
support this idea, we performed PKC family inhibitor ex-
periment and showed that PKC inhibitor-treated Znt5/ 
mast cells were significantly reduced by FcRI-mediated 
degranulation (Fig. S11).
We found that FcRI-mediated NF-B activation was 
defective in the Znt5/ BMMCs; FcRI-induced nuclear 
translocation of p65 was reduced, and FcRI-mediated IB 
phosphorylation  and  its  subsequent  degradation  were  im-
paired. From these results, we concluded that Znt5 is selec-
tively required for FcRI-mediated NF-B activation but 
not for MAPK activation or calcium mobilization. Because 
the expression of IL-6 and TNF- depend on the activation 
of NF-B, which is a master transcription factor that regu-
lates the expression of proinflammatory cytokine and chemo-
kine genes (57), our results indicated that Znt5 is a novel 
player  involved  in  FcRI-induced  cytokine  production 
through NF-B activation.
PKC- and PKC- play important roles in NF-B acti-
vation and function upstream of the Bcl10–MALT1 complex 
in TCR and BCR signaling (41, 42). In mast cells, PKC is JEM VOL. 206, June 8, 2009 
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by dividing the 4-p-nitrophenol absorbance in the supernatant by the sum of 
the absorbance in the supernatant and detergent-solubilized cell pellet.
Measurement of cytokines and chemical mediators. Cells were acti-
vated as described in the previous sections, and TNF- and IL-6 in the cell 
culture supernatants were measured with an ELISA kit (eBioscience). The 
leukotrienes were quantified using an ELISA kit (Cayman Chemical), ac-
cording to the manufacturer’s instructions.
Cell lysates and immunoblotting. 1 × 106/ml BMMCs were sensitized 
with 1 µg/ml IgE for 6 h at 37°C. Cells were stimulated with 100 ng/ml 
DNP-HSA. After the stimulation, the cells were harvested and lysed with 
100 µl of lysis buffer (20 mM Tris-HCl, pH 7.4, at 4°C, 150 mM NaCl, 1% 
NP-40, 0.1% SDS, 0.1% deoxycholate, 1 mM NaVO4, 3 mM EDTA, and 
proteinase inhibitors [0.5 mM PMSF, 10 µg/ml aprotinin, 5 µg/ml pep-
statin, and10 µg/ml leupeptin]) for 30 min at 4°C and spun at 15,000 g at 
4°C for 15 min. The eluted and reduced samples were resolved by SDS-
PAGE using a 5–20% gradient polyacrylamide gel (Wako Chemicals USA, 
Inc.) and transferred to a PVDF membrane (Immobilon-P; Millipore). For 
immunoblotting, the membranes were incubated with anti–phospho-ERK, 
anti–phospho-JNK, anti–phospho-p38, anti-ERK, anti-JNK, anti-p38, 
anti–phospho-IB, anti-IB, anti–-tubulin, anti-actin, and anti–PKC-, 
respectively. For immunoprecipitation, the cell lysates were incubated for 
4 h at 4°C with 1 µg of antibodies bound to protein A Sepharose. The eluted 
and reduced samples were separated on a 5–20% gradient SDS-polyacryl-
amide gel and transferred to a PVDF membrane. The membranes were in-
cubated with antiphosphotyrosine. After blotting with the first antibody, the 
membranes were blotted with HRP-conjugated species-specific anti-IgG 
(Invitrogen) for 1 h at room temperature. After extensive washing of the 
membranes, the immunoreactive proteins were visualized using the Renais-
sance chemiluminescence system (Dupont), according to the manufacturer’s 
recommendations. The PVDF membranes were exposed to RX film (Fujifilm). 
Densitometric analysis for tubulin and PKC- was performed using a fluo-
rescence image analyzer (LAS-1000; Fujifilm).
Preparation of plasma membrane protein. Plasma membrane proteins 
were extracted using a Plasma Membrane Protein Extraction kit ( K268-50; 
BioVision, Inc.), according to the manufacturer’s instructions. The plasma 
membrane fractions were used for immunoblotting and probed with anti-
actin, anti–PKC-, and anti–phospho-PKC (S660). Densitometric analysis 
for PKC-, phospho-PKC (S660), and actin was performed using an LAS-
1000 fluorescence image analyzer.
Confocal microscopy. Separate aliquots of 5 × 105 cells were sensitized with 
1 µg/ml IgE for 6 h. The cells were then stimulated with 100 ng/ml DNP-
HSA for 10 min at 37°C and fixed with 4% paraformaldehyde for 30 min. The 
cells were spun and permeabilized in Perm Buffer (BD) containing 1% BSA 
for 15 min at room temperature. The cells were washed with 1 ml PBS (PBS 
without calcium and magnesium) twice, resuspended in 500 µl of PBS, and 
attached to glass slides by cytospin (Thermo Fisher Scientific) for 5 min. Pri-
mary and secondary staining were performed on the slides, with anti-p65 at a 
dilution of 1:50, anti–PKC- at 1:100, Alexa Fluor 488–conjugated anti–rabbit 
IgG (Invitrogen) at 1:100, and phalloidin-rhodamine (Invitrogen) at 1:100. 
Confocal microscopy was performed using the TCS SL system (Leica).
RT-PCR  and  real-time  quantitative  RT-PCR  analysis. Cells were 
homogenized with Sepasol RNAI (Nacalai Tesque, Inc.), and the to-
tal RNA was isolated according to the manufacturer’s instructions. For 
standard RT-PCR, cDNA was synthesized from 500 ng of total RNA by 
RT (ReverTra Ace; TOYOBO) and 500 ng of oligo (dT) primer (Invitro-
gen) for 30 min at 42°C. A portion of the cDNA (typically 1/20 vol) was 
used for standard PCR to detect IL-6, TNF-, and GAPDH. 25 cycles 
of PCR were performed with 0.5 U rTaq DNA polymerase and 10 pmol 
of  gene-specific  sense  and  antisense  primers.  For  real-time  quantitative 
RT-PCR,  IL-6  and  TNF-  gene  expression  was  measured  relative  to 
Antibodies and reagents. Anti-Znt5 antibodies were raised by immu-
nizing rabbits with KLH-conjugated peptide (TIQVEKEAYFQHMSG). 
For the immunization, rabbits were first injected with 200 µg of KLH-
conjugated Znt5 peptide in complete Freund’s adjuvant and then boosted 
every week with 50 µg of the antigen in incomplete Freund’s adjuvant. 
Anti-GFP  and  antiphosphotyrosine  (4G10)  antibodies  were  purchased 
from  MBL  and  Millipore,  respectively.  Anti-Flag  (M2),  anti-GM130, 
anti–PKC- (C-16), anti–phospho-PKC (S660), and anti-LAT antibodies 
were obtained from Sigma-Aldrich, BD, Santa Cruz Biotechnology, Inc., 
Cell Signaling Technology, and Millipore, respectively. Gö6976 was pur-
chased from EMD.
FITC-induced CHS. The FITC-induced CHS procedure was performed 
as described previously (31). In brief, mice were sensitized with a total of 200 µl 
of 2% FITC isomer-I (FITC; Sigma-Aldrich) in a vehicle consisting of ace-
tone-dibutylphthalate (1:1) applied to the skin of the back. 5 d after the sen-
sitization with FITC, the mice were challenged with 40 µl of vehicle alone 
on the right ear (20 µl on each side of the ear) and 0.5% FITC on the left ear 
(20 µl on each side). Ear thickness was measured before and at multiple in-
tervals after FITC challenge with an engineer’s microcaliper (Ozaki). Some 
mice from each group were killed 24 h after the FITC or vehicle challenge 
for cytokine analysis.
For mast cell reconstitution studies, BMMCs were injected intradermally 
(1.0 × 106 cells in 20 µl/ear for CHS) in 6-wk-old KitW-sh/W-sh mice. The mice 
were used for CHS experiments at 6 wk after transfer of BMMCs.
PCA and histology of the ears. A total of 2 µg IgE was injected subcuta-
neously into ears for 12 h. After this sensitization, the mice were then chal-
lenged with an intravenous injection of 250 µg of polyvalent DNP-BSA 
(Cosmo Bio Co., LTD.) in 250 µl of saline and 5 mg/ml of Evans blue dye 
(Sigma-Aldrich). The extravasation of Evans blue into the ear was moni-
tored for 30 min. The mice were then sacrificed, both ears were dissected, 
and the Evans blue dye was extracted in 700 µl of formamide at 63°C over-
night. The absorbance of the Evans blue–containing formamide was then 
measured at 620 nm. To observe the ear mast cells, 3-µm paraffin sections 
were fixed and stained with nuclear fast red and Alcian blue, and the Alcian 
blue–stained cells in each sample were counted. All data are expressed as the 
number of mast cells per mm2 of dermis.
Primary mast cell cultures and cell lines. BMMCs were prepared as 
described previously (63). In brief, BM cells were flushed from the marrow 
cavity of mouse femurs, and the mast cells (BMMCs) were selectively grown 
in RPMI1640 medium supplemented with IL-3 (conditioned medium from 
an  mIL-3–producing  cell  line,  CHOmIL-3-3-12M  [gift  from  T.  Sudo, 
Toray Industries, Inc., Kamakura, Japan]), 10% FBS, 10 mU/ml penicillin, 
and 0.1 mg/ml streptomycin for 4–8 wk. During culture, the medium was 
changed every 3–4 d, and the cells were transferred to new dishes to elimi-
nate adherent cells. After 5 wk in culture, the BMMCs were ready for in vi-
tro experiments and showed the cell surface expression of FcRI and c-Kit. 
HeLa cells were maintained in RPMI1640 supplemented with 10% FBS, 
penicillin, and streptomycin.
Degranulation assay. The degranulation assay was described previously 
(64). In brief, the degree of degranulation was determined by measuring the 
release of -hexosaminidase. 1 × 106 cells/ml were preloaded with 1 µg/ml 
anti-DNP  IgE  (SPE-7;  Sigma-Aldrich)  by  a  6-h  incubation  in  medium 
(without IL-3). To measure -hexosaminidase release, the sensitized cells 
were stimulated with 100 ng/ml DNP-HSA for 30 min in Tyrode’s buffer. 
Samples were placed on ice and then spun at 4°C for 5 min. The enzymatic 
activities of -hexosaminidase in the supernatants and cell pellets solubilized 
with 1% Triton X-100 in Tyrode’s buffer were measured with p-nitrophenyl 
N-acetyl--d-glucosaminide (Sigma-Aldrich) in 0.1 M sodium citrate, 
pH 4.5, for 60 min at 37°C. The reaction was stopped by the addition of   
0.2 M glycine, pH 10.7. The release of the product 4-p-nitrophenol was de-
tected by absorbance at 405 nm. The extent of degranulation was calculated 1362 ROLE OF ZN TRANSPORTER IN ALLERGIC RESPONSE | Nishida et al.
and transferred to a PVDF membrane (Immobilon-P; Millipore). For immuno-
blotting, the membrane was incubated with Biotinyl-PMA or anti–PKC- 
antibody. After the membrane was washed in TBST, the coloring reaction was 
performed with streptavidin-AP (Roche) or anti–rabbit IgG HRP antibody, 
respectively. Densitometric analysis for PKC- and PMA was performed 
using an LAS-1000 fluorescence image analyzer (Fujifilm).
Statistical analysis. All data were analyzed with Statcell (Microsoft). Data 
were considered statistically significant for p-values <0.05, obtained with a 
two-tailed Student’s t test.
Online  supplemental  material. Fig. S1 shows expression level of Znt 
family member in BMMCs. Fig. S2 shows expression level of Znt5 after 
antigen stimulation. Fig. S3 shows normal development of BMMC from 
Znt5/ mice. Fig. S4 shows normal development of mast cell in Znt5/ 
mice. Fig. S5 shows numbers of mast cells in dermis from vehicle-treated 
or FITC-challenged ears. Fig. S6 shows quantitative analysis of IB phos-
phorylation and degradation. Fig. S7 shows normal FcRI-induced calcium 
signaling and influx in Znt5/ BMMCs. Fig. S8 shows impairment of PKC 
activity in Znt5/ BMMCs. Fig. S9 shows normal expression levels of 
PKC- in Znt5/ BMMCs. Fig. S10 shows design of biotinyl-PMA and 
that biotinyl-PMA can induce cytokine production. Fig. S11 shows that the 
PKC inhibitor Gö6976 inhibits FcRI-induced degranulation in Znt5/ 
BMMCs. Video 1 shows time-lapse images of WT PKC-–EGFP in HeLa 
cells after PMA stimulation. Video 2 shows time-lapse images of C1AS PKC-
–EGFP in HeLa cells after PMA stimulation. Video 3 shows time-lapse im-
ages of C1BS PKC-–EGFP in HeLa cells after PMA stimulation. Video 4 
shows time-lapse images of C1ABS PKC-–EGFP in HeLa cells after PMA 
stimulation. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20082533/DC1.
We thank Drs. Y. Nakamura and T. Tanaka (University of Tokyo and RIKEN, Center 
for Genomic Medicine) for providing the Znt5/ mice. We would like to thank 
Drs. P. Burrows for critical readings and K. Kabu, T. Suzuki, T. Kambe, A. Hijikata, H. 
Shinohara, H. Kitamura, and H. Watarai for technical advice and suggestions. We also 
thank Ms. A. Ito, Ms. M. Yamada, Ms. M. Hara, Mr. S. Fukuda, and Ms. N. Hashimoto 
for excellent technical assistance and Ms. M. Shimura for secretarial assistance.
This work was supported by grants from the Ministry of Education, Culture, 
Sports, Science and Technology in Japan.
The authors have no conflicting financial interests.
submitted: 7 november 2008
accepted: 22 april 2009
REFERENCES
  1.  Vallee, B.L., and K.H. Falchuk. 1993. The biochemical basis of zinc 
physiology. Physiol. Rev. 73:79–118.
  2.  Prasad, A.S. 1995. Zinc: an overview. Nutrition. 11:93–99.
  3.  Rink, L., and P. Gabriel. 2000. Zinc and the immune system. Proc. 
Nutr. Soc. 59:541–552.
  4.  Fernandes, G., M. Nair, K. Onoe, T. Tanaka, R. Floyd, and R.A. 
Good. 1979. Impairment of cell-mediated immunity functions by di-
etary zinc deficiency in mice. Proc. Natl. Acad. Sci. USA. 76:457–461. 
  5.  Fraker, P.J., R. Caruso, and F. Kierszenbaum. 1982. Alteration of the 
immune and nutritional status of mice by synergy between zinc defi-
ciency and infection with Trypanosoma cruzi. J. Nutr. 112:1224–1229.
  6.  Keen, C.L., and M.E. Gershwin. 1990. Zinc deficiency and immune 
function. Annu. Rev. Nutr. 10:415–431. 
  7.  Ibs, K.H., and L. Rink. 2003. Zinc-altered immune function. J. Nutr. 
133:1452S–1456S.
  8.  Eide, D.J. 2004. The SLC39 family of metal ion transporters. Pflugers 
Arch. 447:796–800. 
  9.  Vallee, B.L., and D.S. Auld. 1995. Zinc metallochemistry in biochem-
istry. EXS. 73:259–277.
  10.  Andrews, G.K. 2001. Cellular zinc sensors: MTF-1 regulation of gene 
expression. Biometals. 14:223–237. 
GAPDH using the SYBR Green system (Applied Biosystems). Primers used   
in these experiments were purchased from Invitrogen, and the sequences   
were as follows: IL-6 forward, 5-GAGGATACCACTCCCAACAG-
ACC-3  and  reverse,  5-AAGTGCATCATCGTTGTTCATACA-3; 
TNF- forward, 5-CATCTTCTCAAAATTCGAGTGACAA-3 and 
reverse, 5-TGGGAGTAGACAAGGTACAACCC-3; GAPDH forward, 
5-TTCACCACCATGGAGAAGGCCG-3  and  reverse,  5-GGCATG-
GACTGTGGTCATGA-3; and hypoxanthine-guanine phosphoribosyl 
transferase forward, 5-CCTCCCATCTCCTTCATGACA-3 and reverse, 
5-GATTAGCGATGATGAACCAGGTT-3. In addition, primers used   
for amplifying cDNAs for Znt family members and other primer sets are listed 
in Table S1. PCR products were separated on an agarose gel, stained with 
500 ng/ml ethidium bromide, and photographed.
Intracellular Zn measurement. 2 × 106 BMMCs were treated with 2.5 µM 
of Newport green for 30 min at 37°C. The cells were washed two times with 
PBS before the fluorescence intensity was measured by FACS. The concen-
tration of intracellular free Zn was calculated from the mean fluorescence with 
the formula [Zn] = KD × [(F  Fmin)/(Fmax  F)]. The dissociation constant 
of the Newport Green/Zn complex is 1 µM. Fmin was determined by the ad-
dition of the Zn-specific membrane-permeant chelator TPEN, and Fmax was 
determined by the addition of ZnSO4 and the ionophore pyrithione (65).
Calcium influx measurement. 1 × 106 BMMCs/ml were sensitized with 
1 µg/ml IgE (anti-DNP IgE clone SPE-7; Sigma-Aldrich) for 6 h at 37°C. 
IgE-sensitized mast cells were washed three times, resuspended in Tyrode’s 
buffer (10 mM Hepes, pH 7.4, 130 mM NaCl, 5 mM KCl, 1.4 mM CaCl2, 
1 mM MgCl2, and 5.6 mM glucose), allowed to adhere to a poly-l-lysine–
coated glass-bottom dish, and incubated with 5 µM Fluo-4, a cell-permeant 
dye, for 30 min at 37°C. Surplus fluorescence indicator and floating cells 
were removed by at least three washes with Tyrode’s buffer. Cells were 
stimulated with 100 ng/ml DNP–HSA (Sigma-Aldrich) at 37°C. Images of 
the fluorescent signals were captured every 10 or 30 s from an inverted mi-
croscope (Axiovert 200 MOT; Carl Zeiss, Inc.) equipped with an oil Plan 
Neofluar 100× 1.3 NA objective, a charge-coupled device camera (Cool 
Snap HQ; Roper Scientific), and the system control application SlideBook 
(Intelligent Imaging Innovation) at 25°C. The captured images were pro-
cessed with Photoshop software (Adobe) to adjust their size and contrast.
cDNA cloning and plasmid construction. PKC- was cloned by PCR 
using cDNA from BMMCs and sequenced on a 3130xl sequencer (ABI-
PRISM; APplied Biosystems). The GFP-tagged expression vectors for 
PKC- were constructed and subcloned into pEGFP N1 (Invitrogen). The 
construct encoding mutant PKC-–GFP, in which the Zn finger–like motif 
in the C1 region was mutated, was made using a PCR-based method. The 
human Znt5 cDNA in pA-Zeocin was reported in detail by Suzuki et al. 
(62). HeLa cells were transfected with a total of 1 µg PKC- cDNA in 
pEGFP or with empty vector using Lipofectamine 2000 (Invitrogen).
Retroviral infection. Retroviral infection was performed as previously de-
scribed (64). The Flag-tagged human Znt5 plasmid (gift from T. Kambe and 
T. Suzuki, Kyoto University, Kyoto, Japan) was inserted into the BamHI and 
NotI sites of the retroviral vector pMX (gift from T. Kitamura, University of 
Tokyo, Tokyo, Japan). This construct was then used to transfect the 293T-
based packaging cell line phoenix (gift from G. Nolan, Stanford University, 
Stanford, CA), with Lipofectamine 2000 (Invitrogen) to generate recombi-
nant retroviruses. BM cells were infected with the retrovirus in the presence 
of 10 µg/ml polybrene (Sigma-Aldrich) and IL-3.
Biotinyl-PMA and native PAGE. PMA (Nacalai Tesque, Inc.) was conju-
gated with biotin (Wako Chemicals USA, Inc.). The predicted biotinyl-PMA 
is shown in Fig. S10. Native PAGE was performed with the NativePAGE 
Novex Bis-Tris Gel system (Invitrogen). In detail, the cells were lysed with 
NativePAGE Sample buffer for 10 min at 4°C and spun at 15,000 g at 4°C for 
10 min. The samples were separated by native PAGE on 4–16% Bis-Tris Gels JEM VOL. 206, June 8, 2009 
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